Answers are grounded in this paper and cite their sources.
Correction note updates findings on FGFR2/STAT3 signaling and breast cancer in TA2 mice, implying revised insights into tumor development.
Correction on: Du J, Zhao Q, Liu K, Li Z, Fu F, Zhang K, Zhang H, Zheng M, Zhao Y and Zhang S (2020) FGFR2/STAT3 Signaling Pathway Involves in the Development of MMTV-Related Spontaneous Breast Cancer in TA2 Mice. Front. Oncol. 10:652. doi: 10.3389/fonc.2020.00652There was a mistake in figure (figure 3) as published. [Figure 3B (c) and figure 3B (g) are duplicates. Figure 3B (e) and Figure 3B(f) are also duplicates.] The corrected figure (figure 3) appears below.Last Name author1 et al.The original version of this article has been updated.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: